최보윤

최보윤 교수

전공임상약학
연락처 031-850-9443 boyoon1@cha.ac.kr

학력

  • 서울대학교 약학대학, 약학사
  • 서울대학교 약학대학, 약학석사, 임상약학 전공
  • 서울대학교 약학대학, 약학박사, 임상약학 전공


  • [전문분야]
  • Real-world data analytics
  • Pharmacometrics
  • Pharmacogenomics
  • Drug safety evaluation
  • Pharmaceutical care service
  • Pharmacotherapy in hemato-oncologic disease

경력

  • (현) 차 의과학대학교 약학대학 조교수
  • (현) 한국의약품안전관리원 의약품부작용 전문위원
  • (현) 한국임상약학회 교재편찬위원
  • 한국임상약학회 총무위원
  • 한국임상약학회 정책기획위원
  • 한국보건의료정보원 인증기준 자문위원
  • 서울대학교 종합약학연구소 연구원
  • 서울대학교병원 혈액종양내과 및 약물안전센터 임상약사


  • [기타]
  • Valid Board Certified Pharmacotherapy Specialist (BCPS), U.S.
  • 서울대학교 NLRL 연구센터 및 충남대학교 BK21 신의약사업단 우수연구상 수상
  • 한국임상약학회 젊은임상약과학자상 수상


  • [연구실소개]

    본 연구실은 보험청구자료 등의 빅데이터(Big data) 및 실사용자료(Real-world data) 분석, 그리고 약물계량학(Pharmacometrics) 및 약물유전체학(Pharmacogenomics) 연구를 통하여 약물치료의 유효성과 안전성을 극대화하기 위한 연구를 수행하고 있습니다. 특별히 혈액종양질환(hemato-oncologic disease)에 대한 연구를 중점적으로 수행하고 있습니다. 또한 환자중심 약물치료를 구현하기 위하여 임상약사의 약료서비스(pharmaceutical care)를 개발하고 표준화하기 위한 방안을 함께 연구 중입니다.

논문

  • [해외논문]
  • Boyoon Choi, Kyungim Kim, Hyun Jin Park, Yun-Kyoung Song, and Jung Mi Oh. Utilization and adherence of onsite clinics among employees with confirmed or suspected chronic diseases at a semiconductor company. PLOS ONE. 2025 Apr 24;e0321252. Doi: https://doi.org/10.1371/journal.pone.0321252
  • Ha Young Jang†, Boyoon Choi†, In-Wha Kim, Hye Ryun Kang, and Jung Mi Oh. Risk factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2024 Dec 24;13(3):610. Doi: 10.1016/j.jaip.2024.12.021.
  • Hyun Jin Park, Boyoon Choi, Yun-Kyoung Song, Yoon-Jeong Oh, Eun Bong Lee, In-Wha Kim, and Jung Mi Oh. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study. Journal of Clinical Medicine. 2023 Sep 12;6998. Doi: https://doi.org/10.3390/jcm12226998
  • Boyoon Choi, Hyun Jin Park, Yun-Kyoung Song, Yoon-Jeong Oh, In-Wha Kim, and Jung Mi Oh. The Risk of Newly Diagnosed Cancer in Patients with Rheumatoid Arthritis by TNF Inhibitor Use: A Nationwide Cohort Study. Arthritis Research & Therapy. 2022 Aug 9;24(1):191. Doi: 10.1186/s13075-022-02868-w.
  • Yun-Kyoung Song, Boyoon Choi, Jung Mi Oh, Arim Kwak, Kyungim Kim. Employee Perspectives on Onsite Health Clinics in Semiconductor. International Journal of Environmental Research and Public Health. 2022 Oct; 19:1433. doi: 10.3390/ijerph19031433.
  • Yun-Kyoung Song†, Boyoon Choi†, Kyungim Kim, Hyun Jin Park, and Jung Mi Oh. Factors Influencing Workplace Health Promotion Interventions for Workers in the Semiconductor Industry According to Risk Levels of Chronic Disease. International Journal of Environmental Research and Public Health. 2021 Oct; 18(21):11383-11398. Doi: 10.3390/ijerph182111383.


  • [국내논문]
  • Dong-Yeop Lee†, Boyoon Choi†, Seung Hei Moon, Eun Young Choi, and Dong Yoon Kang. Awareness of Drug Safety System in Local Clinics in Korea. Pharmacoepidemiology and Risk Management. 2024 Mar;16:57-64
  • Sang-Bong Lee, Dong-Yeop Lee, Ji-Hyun Kim, Seung Hei Moon, Gwijin Lee, Boyoon Choi, Ye Seul Kim, Jae Hyoung Im and Dong Yoon Kang. Analysis of Treatment-Related Adverse Events in Hospitalized Patients with Coronavirus Disease 2019. Pharmacoepidemiology and Risk Management. 2023 Jun;15:128-136
  • Boyoon Choi, Ha Young Jang, Hye-Ryun Kang, and Jung Mi Oh. Hypersensitivity Reactions to Anticancer Monoclonal Antibodies. Pharmacoepidemiology and Risk Management. 2023 Mar; 15(1):1-10

저서/역서/편서